CrossrefInfokarte
Clinical and Economic Impact of Nirsevimab and Bivalent Maternal Vaccine Against RSV Infections in Infants in Italy
ClinicoEconomics and Outcomes Research · 2026-11 · Volume 18 · 1-13
DOI: 10.2147/ceor.s622013 ↗Abstract
Kein Abstract verfügbar.
EUVIMED